Focused Wealth Management’s Microbot Medical MBOT Stock Holding History

Focused Wealth Management’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	–	–	750
2019 Q3	$0	Hold	1	–	–	﹤0.01%	748
2019 Q2	$0	Hold	1	–	–	﹤0.01%	776
2019 Q1	$0	Hold	1	–	–	﹤0.01%	739
2018 Q4	$0	Hold	1	–	–	﹤0.01%	731
2018 Q3	$0	Buy	+1	New	+$9	﹤0.01%	694
2018 Q2	–	Hold	0	–	–	–	715
2018 Q1	–	Hold	0	–	–	–	726
2017 Q4	–	Hold	0	–	–	–	721
2017 Q3	–	Hold	0	–	–	–	703
2017 Q2	–	Hold	0	–	–	–	728
2017 Q1	–	Hold	0	–	–	–	713
2016 Q4	–	Hold	0	–	–	–	719
2016 Q3	–	Hold	0	–	–	–	687
2016 Q2	–	Hold	0	–	–	–	702
2016 Q1	–	Hold	0	–	–	–	696
2015 Q4	–	Hold	0	–	–	–	703
2015 Q3	–	Hold	0	–	–	–	702
2015 Q2	–	Hold	0	–	–	–	683
2015 Q1	–	Hold	0	–	–	–	692
2014 Q4	–	Hold	0	–	–	–	686
2014 Q3	–	Hold	0	–	–	–	645
2014 Q2	–	Hold	0	–	–	–	633
2014 Q1	–	Hold	0	–	–	–	597
2013 Q4	–	Hold	0	–	–	–	632

Other funds holding MBOT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Focused Wealth Management's MBOT Position: Q4 2019 in Review

Focused Wealth Management sold out of Microbot Medical (MBOT) in Q4 2019, closing a stake of 1 share.

Focused Wealth Management first reported a position in MBOT in Q3 2018 and held it in 5 quarters. The position peaked at $0 in Q3 2019. 28 funds tracked by Wall St. Rank hold MBOT as of Q4 2019.

Focused Wealth Management reported no remaining Microbot Medical position as of Q4 2019 after selling out during the quarter.
Focused Wealth Management sold 1 Microbot Medical share in Q4 2019.
Focused Wealth Management first reported a position in Microbot Medical in Q3 2018 and held it in 5 quarters.
Focused Wealth Management's Microbot Medical position peaked at $0 in Q3 2019.
28 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2019.

Based on Focused Wealth Management's 13F filing for Q4 2019, filed 21 Jan 2020.